Puma Biotechnology Changes Fiscal Year End

Ticker: PBYI · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1401667

Puma Biotechnology, Inc. 8-K Filing Summary
FieldDetail
CompanyPuma Biotechnology, Inc. (PBYI)
Form Type8-K
Filed DateJun 24, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-action, fiscal-year-change, financial-reporting

TL;DR

Puma Biotech is shifting its fiscal year end to Dec 31st, effective June 19, 2025.

AI Summary

Puma Biotechnology, Inc. filed an 8-K on June 24, 2025, reporting a change in its fiscal year end to December 31st. This change was effective as of June 19, 2025. The filing also includes financial statements and exhibits.

Why It Matters

A change in fiscal year end can impact reporting schedules and financial analysis timelines for investors.

Risk Assessment

Risk Level: low — This filing is administrative and does not involve significant financial transactions or strategic shifts that would inherently increase risk.

Key Numbers

  • 1231 — Fiscal Year End (The company's fiscal year will now end on December 31st.)

Key Players & Entities

  • PUMA BIOTECHNOLOGY, INC. (company) — Registrant
  • June 19, 2025 (date) — Effective date of fiscal year change
  • December 31 (date) — New fiscal year end
  • 10880 Wilshire Boulevard, Suite 2150 Los Angeles, California 90024 (address) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a change in Puma Biotechnology, Inc.'s fiscal year end and to include financial statements and exhibits.

When is the new fiscal year end effective?

The change in fiscal year end is effective as of June 19, 2025.

What is the new fiscal year end date for Puma Biotechnology, Inc.?

The new fiscal year end date for Puma Biotechnology, Inc. is December 31st.

Where are Puma Biotechnology, Inc.'s principal executive offices located?

Puma Biotechnology, Inc.'s principal executive offices are located at 10880 Wilshire Boulevard, Suite 2150, Los Angeles, California 90024.

What was the former company name before Puma Biotechnology, Inc. adopted its current name?

The former company name was INNOVATIVE ACQUISITIONS CORP, with a date of name change on June 1, 2007.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding PUMA BIOTECHNOLOGY, INC. (PBYI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.